Selected article for: "different target and RNA polymerase"

Author: Gazina, Elena V.; Petrou, Steven
Title: Viral targets of acylguanidines
  • Cord-id: 3jnszsrg
  • Document date: 2012_5_8
  • ID: 3jnszsrg
    Snippet: Acylguanidines are a new class of antiviral compounds with the unique ability to target both RNA polymerase and transmembrane proteins of viruses from different families. Importantly, they inhibit proteins which are not targeted by existing antiviral therapies, for example, Vpu of HIV type 1, p7 of hepatitis C virus, E of severe acute respiratory syndrome coronavirus and RNA-dependent RNA polymerase of coxsackievirus B3. BIT225, developed by Biotron Limited, is the first acylguanidine in clinica
    Document: Acylguanidines are a new class of antiviral compounds with the unique ability to target both RNA polymerase and transmembrane proteins of viruses from different families. Importantly, they inhibit proteins which are not targeted by existing antiviral therapies, for example, Vpu of HIV type 1, p7 of hepatitis C virus, E of severe acute respiratory syndrome coronavirus and RNA-dependent RNA polymerase of coxsackievirus B3. BIT225, developed by Biotron Limited, is the first acylguanidine in clinical trials against HIV type 1 and hepatitis C virus. In this article we focus on the mechanisms of inhibition of viral proteins by acylguanidines.

    Search related documents:
    Co phrase search for related documents
    • accessory protein and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • accessory protein and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acid envelope and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5
    • acid envelope and acute sars cov respiratory syndrome coronavirus: 1
    • acid envelope protein and active site: 1
    • acid envelope protein and acute respiratory syndrome coronavirus: 1
    • acid envelope protein and acute sars cov respiratory syndrome coronavirus: 1
    • acid sensitivity and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • acid sensitivity and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acidic environment and acute respiratory syndrome coronavirus: 1, 2, 3, 4
    • acidic environment and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4
    • active site and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • active site and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • active site and additional target: 1, 2, 3, 4
    • acute respiratory syndrome coronavirus and additional target: 1, 2, 3, 4
    • acute sars cov respiratory syndrome coronavirus and additional target: 1, 2, 3